In vivo pharmacodynamic evaluation of the novel nystatin derivative BSG005 in the invasive candidiasis and invasive pulmonary aspergillosis mouse models.

Autor: Lepak AJ; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Massey J; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Zarnowski R; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Olesen TK; Biosergen AS, Trondheim, Norway., Jones R; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Andes DR; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medical Microbiology and Immunology, University of Wisconsin, Madison, Wisconsin, USA.; William S. Middleton Memorial VA Hospital, Madison, Wisconsin, USA.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Dec 05; Vol. 68 (12), pp. e0123424. Date of Electronic Publication: 2024 Oct 29.

The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometrics.

Autor: Andes D; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA., Brüggemann RJ; Department of Pharmacy and Radboudumc Institute for Medical Innovation, Radboud University Medical Center, and Radboudumc-CWZ Nijmegen Center of Expertise in Mycology, Nijmegen, The Netherlands., Flanagan S; Cidara Therapeutics, San Diego, CA, USA., Lepak AJ; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA., Lewis RE; Department of Molecular Medicine, University of Padua, Padua, Italy., Ong V; Cidara Therapeutics, San Diego, CA, USA., Rubino CM; Institute for Clinical Pharmacodynamics, Inc., Schenectady, NY, USA., Sandison T; Cidara Therapeutics, San Diego, CA, USA.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Nov 14. Date of Electronic Publication: 2024 Nov 14.

Understanding clinical implementation coordinators' experiences in deploying evidence-based interventions.

Autor: Hernandez SE; School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA., Solomon D; Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA., Moon J; School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA., Parmasad V; School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA., Wiegmann D; Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA., Bennett NT; Antimicrobial Stewardship Program, Saint Luke's Health System, Kansas City, MO, USA., Ferren RS; University of Texas Medical Branch, Galveston, TX, USA., Fitzsimmons AJ; Department of Medical Research, Gundersen Health System, La Crosse, WI, USA., Lepak AJ; School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA., O'Horo JC; Mayo Foundation for Medical Education and Research, Rochester, MN, USA., Pop-Vicas AE; School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA., Schulz LT; Department of Pharmacy, University of Wisconsin Health, Madison, WI, USA., Safdar N; School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.

Publikováno v: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2024 Feb 08; Vol. 81 (4), pp. 120-128.

Neutropenic Fever-Associated Admissions Among Patients With Solid Tumors Receiving Chemotherapy During the COVID-19 Pandemic.

Autor: Baus CJ; University of Wisconsin School of Pharmacy, Madison., Kelley B; University of Wisconsin School of Medicine and Public Health, Madison., Dow-Hillgartner E; University of Wisconsin School of Pharmacy, Madison.; University of Wisconsin Carbone Cancer Center, Madison., Kyriakopoulos CE; University of Wisconsin Carbone Cancer Center, Madison.; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison., Schulz LT; University of Wisconsin School of Pharmacy, Madison., Lepak AJ; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison., LoConte NK; University of Wisconsin Carbone Cancer Center, Madison.; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison.

Publikováno v: JAMA network open [JAMA Netw Open] 2023 Mar 01; Vol. 6 (3), pp. e234881. Date of Electronic Publication: 2023 Mar 01.

Validated Preclinical Mouse Model for Therapeutic Testing against Multidrug-Resistant Pseudomonas aeruginosa Strains.

Autor: Warawa JM; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA.; Department of Microbiology and Immunology, University of Louisvillegrid.266623.5 School of Medicine, Louisville, Kentucky, USA., Duan X; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA., Anderson CD; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA., Sotsky JB; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA., Cramer DE; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA., Pfeffer TL; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA., Guo H; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA.; Department of Radiology, University of Louisvillegrid.266623.5 School of Medicine, Louisville, Kentucky, USA., Adcock S; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA., Lepak AJ; Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA., Andes DR; Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA., Slone SA; Dr. Bing Zhang Department of Statistics, University of Kentuckygrid.266539.d, Lexington, Kentucky, USA., Stromberg AJ; Dr. Bing Zhang Department of Statistics, University of Kentuckygrid.266539.d, Lexington, Kentucky, USA., Gabbard JD; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA., Severson WE; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA., Lawrenz MB; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA.; Department of Microbiology and Immunology, University of Louisvillegrid.266623.5 School of Medicine, Louisville, Kentucky, USA.

Publikováno v: Microbiology spectrum [Microbiol Spectr] 2022 Oct 26; Vol. 10 (5), pp. e0269322. Date of Electronic Publication: 2022 Sep 12.